A technology to analyze how immune cells function and their molecular profiles in cancer treatment
MusIC: A multi-scale technology for integrating dynamic cellular function and molecular profiles
['FUNDING_R01'] · UNIVERSITY OF HOUSTON · NIH-10934345
This study is exploring a new technology that looks closely at immune cells to understand why some cancer patients do better with treatments than others, with the hope of creating more personalized and effective therapies just for you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF HOUSTON (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10934345 on ClinicalTrials.gov |
What this research studies
This research aims to develop a groundbreaking technology that combines the functions of immune cells with their detailed molecular characteristics at a single-cell level. By focusing on immunotherapy, particularly adoptive cell therapy, the project seeks to understand why some patients respond well to treatments while others do not. The approach involves high-throughput analysis, allowing for a comprehensive mapping of cellular responses and molecular signatures. This could lead to more personalized and effective cancer treatments by identifying the best therapeutic strategies for individual patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing immunotherapy for various types of cancers, particularly those receiving adoptive cell therapy.
Not a fit: Patients who are not receiving immunotherapy or those with non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored immunotherapy treatments for cancer patients.
How similar studies have performed: Other research has shown promising results in using similar technologies to enhance the effectiveness of immunotherapy, indicating that this approach has potential for success.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF HOUSTON — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VARADARAJAN, NAVIN — UNIVERSITY OF HOUSTON
- Study coordinator: VARADARAJAN, NAVIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.